OrbusNeich Medical Group Holdings Limited (OrbusNeich) filed its Monthly Return for the period ended 31 May 2026, confirming an unchanged capital structure and continued adherence to Hong Kong’s public-float requirements.

Authorised Capital • The company’s authorised share capital remained at 1.20 billion ordinary shares with a par value of USD 0.0005 each, representing total authorised capital of USD 0.60 million. • No increases or cancellations were recorded during the month.

Issued Shares and Treasury Position • Issued shares (excluding treasury shares) closed the month at 827.97 million, identical to the preceding month. • OrbusNeich held no treasury shares, and no shares were issued, repurchased or cancelled in May.

Public Float • Management confirmed compliance with the Main Board’s minimum public-float threshold of 25% of issued shares as at 31 May 2026.

Share Option Schemes • Pre-IPO Share Option Scheme (adopted 18 December 2020): 7.43 million options outstanding; none exercised during the month. • Post-IPO Share Option Scheme (grant date 10 July 2023, HKD 9 exercise price): 4.35 million options outstanding; none exercised. The scheme still permits a further 76.60 million shares to be granted in future. • No funds were raised from option exercises in May.

Other Equity Instruments • The issuer reported no warrants, convertible securities, or other agreements that could affect share capital.

Overall, OrbusNeich’s share capital, option activity and public-float status remained stable throughout May 2026, with no transactions affecting the number of outstanding or treasury shares.